ORBIMED ADVISORS LLC Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$5.5B
Holdings
139
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (139 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SVASINOVAC BIOTECH LTD | 2,718,735 | $349.5B | 6332.88% | |
| 2 | BMYBRISTOL-MYERS SQUIBB CO | 2,518,700 | $193.9B | 3514.16% | |
| 3 | HUMHUMANA INC | 365,700 | $171.2B | 3101.63% | |
| 4 | HZNPHORIZON THERAPEUTICS PUB L | 2,108,555 | $168.2B | 3047.36% | |
| 5 | BSXBOSTON SCIENTIFIC CORP | 4,369,500 | $162.9B | 2950.83% | |
| 6 | —TURNING POINT THERAPEUTICS I | 2,012,250 | $151.4B | 2743.74% | |
| 7 | SWTXSPRINGWORKS THERAPEUTICS INC | 6,028,307 | $148.4B | 2689.29% | |
| 8 | UNHUNITEDHEALTH GROUP INC | 281,200 | $144.4B | 2617.10% | |
| 9 | PFEPFIZER INC | 2,744,000 | $143.9B | 2606.86% | |
| 10 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,699,710 | $140.9B | 2552.27% | |
| 11 | SGENUSDSEAGEN INC | 737,500 | $130.5B | 2364.51% | Call |
| 12 | ABBVABBVIE INC | 799,800 | $122.5B | 2219.63% | |
| 13 | EWTXEDGEWISE THERAPEUTICS INC | 14,082,680 | $112.1B | 2031.20% | |
| 14 | VRTXVERTEX PHARMACEUTICALS INC | 387,200 | $109.1B | 1977.04% | |
| 15 | TORCEURADICET BIO INC | 7,447,141 | $108.7B | 1970.13% | |
| 16 | —SIERRA ONCOLOGY INC | 1,964,770 | $108.0B | 1957.72% | |
| 17 | —BIOHAVEN PHARMACTL HLDG CO L | 719,034 | $104.8B | 1898.41% | |
| 18 | ISRGINTUITIVE SURGICAL INC | 517,200 | $103.8B | 1880.97% | |
| 19 | ARQTARCUTIS BIOTHERAPEUTICS INC | 4,781,646 | $101.9B | 1846.36% | |
| 20 | 1T7TRICIDA INC | 10,280,947 | $99.5B | 1803.29% | |
| 21 | EWEDWARDS LIFESCIENCES CORP | 1,011,300 | $96.2B | 1742.49% | |
| 22 | —THESEUS PHARMACEUTICALS INC | 17,041,668 | $94.2B | 1707.61% | |
| 23 | PMVPPMV PHARMACEUTICALS INC | 6,563,077 | $93.5B | 1694.64% | |
| 24 | SYKSTRYKER CORPORATION | 441,100 | $87.7B | 1589.98% | |
| 25 | NBIXNEUROCRINE BIOSCIENCES INC | 849,545 | $82.8B | 1500.58% | |
| 26 | ARGXARGENX SE | 194,000 | $73.5B | 1331.86% | |
| 27 | MRTXEURMIRATI THERAPEUTICS INC | 1,090,400 | $73.2B | 1326.35% | |
| 28 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 2,044,000 | $65.3B | 1183.33% | |
| 29 | NTRANATERA INC | 1,811,353 | $64.2B | 1163.18% | Call |
| 30 | TMOTHERMO FISHER SCIENTIFIC INC | 113,400 | $61.6B | 1116.33% | |
| 31 | CRNXCRINETICS PHARMACEUTICALS IN | 3,196,876 | $59.6B | 1080.34% | |
| 32 | CMPXCOMPASS THERAPEUTICS INC | 21,960,850 | $58.2B | 1054.50% | |
| 33 | EVHEVOLENT HEALTH INC | 1,778,000 | $54.6B | 989.38% | |
| 34 | PRLDPRELUDE THERAPEUTICS INC | 10,039,691 | $52.4B | 949.61% | |
| 35 | —KINNATE BIOPHARMA INC | 4,043,629 | $51.0B | 923.93% | |
| 36 | ABCLABCELLERA BIOLOGICS INC | 4,430,768 | $47.2B | 855.04% | Call |
| 37 | RPTXREPARE THERAPEUTICS INC | 3,322,488 | $46.5B | 842.25% | |
| 38 | KROSKEROS THERAPEUTICS INC | 1,679,417 | $46.4B | 840.80% | |
| 39 | SNDXSYNDAX PHARMACEUTICALS INC | 2,323,300 | $44.7B | 809.96% | |
| 40 | SIBNSI-BONE INC | 3,368,000 | $44.5B | 805.57% | |
| 41 | GHGUARDANT HEALTH INC | 1,083,400 | $43.7B | 791.91% | Call |
| 42 | GRCLGRACELL BIOTECHNOLOGIES INC | 7,884,870 | $43.4B | 785.80% | |
| 43 | —MERSANA THERAPEUTICS INC | 9,011,437 | $41.6B | 754.38% | |
| 44 | XENEXENON PHARMACEUTICALS INC | 1,329,200 | $40.4B | 732.66% | |
| 45 | XTNTXTANT MED HLDGS INC | 72,943,918 | $37.9B | 686.63% | |
| 46 | SPRYSILVERBACK THERAPEUTICS INC | 8,740,887 | $37.1B | 671.54% | |
| 47 | —VECTIVBIO HLDG AG | 6,473,561 | $35.0B | 633.41% | |
| 48 | NVLSEURALPINE IMMUNE SCIENCES INC | 4,081,592 | $34.7B | 629.37% | |
| 49 | JANXJANUX THERAPEUTICS INC | 2,836,386 | $34.6B | 627.53% | |
| 50 | THCTENET HEALTHCARE CORP | 656,300 | $34.5B | 625.04% | |
| 51 | 290ACHINOOK THERAPEUTICS INC | 1,896,300 | $33.2B | 600.96% | |
| 52 | PCVXVAXCYTE INC | 1,513,659 | $32.9B | 596.81% | |
| 53 | ACRSACLARIS THERAPEUTICS INC | 2,325,500 | $32.5B | 588.24% | |
| 54 | IOVAIOVANCE BIOTHERAPEUTICS INC | 2,798,441 | $30.9B | 559.81% | |
| 55 | IMAPRELUDE THERAPEUTICS INC | 5,680,186 | $29.7B | 537.27% | |
| 56 | IMAIKENA ONCOLOGY INC | 6,467,691 | $28.7B | 519.17% | |
| 57 | VRNAVERONA PHARMA PLC | 5,694,841 | $23.9B | 432.36% | |
| 58 | SCPHSCPHARMACEUTICALS INC | 4,797,148 | $23.1B | 418.97% | |
| 59 | BIIBBIOGEN INC | 111,600 | $22.8B | 412.41% | |
| 60 | TELATELA BIO INC | 3,027,542 | $21.2B | 384.56% | |
| 61 | PASGPASSAGE BIO INC | 8,931,999 | $21.1B | 381.97% | |
| 62 | —DECIBEL THERAPEUTICS INC | 4,945,192 | $20.8B | 377.24% | |
| 63 | NPCENEUROPACE INC | 4,012,281 | $19.9B | 359.88% | |
| 64 | RXSTRXSIGHT INC | 1,383,500 | $19.5B | 352.97% | |
| 65 | MGTXMEIRAGTX HLDGS PLC | 2,501,618 | $18.9B | 343.14% | |
| 66 | TVTXTRAVERE THERAPEUTICS INC | 772,200 | $18.7B | 339.02% | |
| 67 | PGNYPROGYNY INC | 625,000 | $18.2B | 328.98% | |
| 68 | GILDGILEAD SCIENCES INC | 287,600 | $17.8B | 322.12% | |
| 69 | ALXOALX ONCOLOGY HLDGS INC | 2,186,269 | $17.7B | 320.49% | |
| 70 | ISIIONIS PHARMACEUTICALS INC | 453,400 | $16.8B | 304.14% | |
| 71 | IVVDADAGIO THERAPEUTICS INC | 5,056,000 | $16.6B | 300.50% | |
| 72 | QUREUNIQURE NV | 874,849 | $16.3B | 295.48% | |
| 73 | GHRSGH RESEARCH PLC | 1,622,060 | $16.2B | 293.32% | |
| 74 | RAPTEURRAPT THERAPEUTICS INC | 866,396 | $15.8B | 286.51% | |
| 75 | VTYXVENTYX BIOSCIENCES INC | 1,289,280 | $15.8B | 285.71% | |
| 76 | AMGNAMGEN INC | 57,100 | $13.9B | 251.72% | |
| 77 | BLUBELLUS HEALTH INC NEW | 1,454,800 | $13.4B | 242.64% | |
| 78 | REGNREGENERON PHARMACEUTICALS | 22,200 | $13.1B | 237.79% | |
| 79 | OPHTEURIVERIC BIO INC | 1,361,400 | $13.1B | 237.32% | |
| 80 | —IKENA ONCOLOGY INC | 2,933,941 | $13.0B | 235.50% | |
| 81 | NXTCNEXTCURE INC | 2,711,013 | $12.7B | 230.88% | |
| 82 | SGFYGBPSIGNIFY HEALTH INC | 900,000 | $12.4B | 225.05% | |
| 83 | TBPHTHERAVANCE BIOPHARMA INC | 1,370,250 | $12.4B | 224.94% | |
| 84 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 30,000,000 | $12.2B | 220.16% | |
| 85 | VTGNUSDVISTAGEN THERAPEUTICS INC | 13,421,283 | $11.8B | 214.01% | |
| 86 | ETNBGBP89BIO INC | 3,658,869 | $11.8B | 213.49% | |
| 87 | KZRKEZAR LIFE SCIENCES INC | 1,419,900 | $11.7B | 212.78% | |
| 88 | MISTMILESTONE PHARMACEUTICALS IN | 1,817,521 | $11.2B | 202.54% | |
| 89 | MREOMEREO BIOPHARMA GROUP PLC | 9,711,422 | $10.9B | 197.09% | |
| 90 | DHR 5 04/15/23 BDANAHER CORPORATION | 8,039 | $10.6B | 192.74% | |
| 91 | —GEMINI THERAPEUTICS INC | 5,826,224 | $9.8B | 178.41% | |
| 92 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,578,174 | $9.5B | 172.85% | |
| 93 | TERNTERNS PHARMACEUTICALS INC | 3,791,204 | $9.4B | 170.36% | |
| 94 | ORICORIC PHARMACEUTICALS INC | 2,087,568 | $9.4B | 169.46% | |
| 95 | ERASERASCA INC | 1,667,693 | $9.3B | 168.32% | |
| 96 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 20,000,000 | $9.0B | 163.08% | |
| 97 | JNCEEURJOUNCE THERAPEUTICS INC | 2,928,900 | $8.9B | 160.81% | |
| 98 | CGEMCULLINAN ONCOLOGY INC | 670,787 | $8.6B | 155.81% | |
| 99 | XBISPDR SER TR | 111,800 | $8.3B | 150.45% | |
| 100 | —FUSION PHARMACEUTICALS INC | 3,224,770 | $8.0B | 145.50% |
Page 1 of 2Next